Interaction Checker

Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more


Friday 05 February 2016

ZepatierĀ® (elbasvir/grazoprevir) has been approved by the FDA and is now available on the web, app and printable versions of the interaction charts. 

The recommendations in the charts are based on information provided in the US Prescribing Information. The charts will be updated to include the European product label when EMA approval has been granted and the label is available. 


Awards and commendations
bma-foundation-for-medical-research british-medical-journal-2018 queens_aniversary_prize_2017 rcp-excellence-patient-care-awards-2017 building_better_healthcare_awards_2016